abstract |
The invention provides human cell surface immunomodulators (CSIMM) and polynucleotides which identify and encode CSIMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of CSIMM. |